沃华医药: 关于董事减持公司股份的预披露公告

Core Points - The company, Shandong Wohuah Pharmaceutical Technology Co., Ltd., announced that its board member and secretary, Mr. Zhang Ge, plans to reduce his shareholding by up to 2,514,688 shares within three months after the announcement, which represents approximately 0.44% of the company's total share capital [1][2] - Mr. Zhang currently holds 10,058,753 shares in the company, and the reduction will be conducted through centralized bidding [1][2] - The company confirms that Mr. Zhang has adhered to his previous commitments regarding share transfers and that this reduction plan aligns with his previously disclosed intentions [2] Shareholding and Reduction Plan - Mr. Zhang's shareholding reduction is consistent with his commitment made at the time of the company's initial public offering, where he agreed not to transfer shares for 12 months and to limit annual transfers to 25% of his holdings during his tenure as a director [1][2] - The reduction plan will be subject to adjustments based on any corporate actions such as dividends or stock splits [1] Compliance and Regulations - The company and Mr. Zhang will comply with relevant regulations, including the "Interim Measures for the Management of Shareholders' Reduction of Shares" and other applicable guidelines [2]